tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
:1099
Hong Kong Market
1099
Sinopharm Group Co
RESEARCH TOOLSreports
Want to see HK:1099 full AI Analyst Report?

Sinopharm Group Co (1099) Income Statement

10 Followers

Sinopharm Group Co Income Statement

Last quarter (Q4 2025), Sinopharm Group Co's total revenue was ¥289.12B, a decrease of -2.20% from the same quarter last year. In Q4, Sinopharm Group Co's net income was ¥3.69B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 575.17B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
Gross Profit
¥ 41.67B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
Operating Expenses
¥ 25.63B¥ 28.07B¥ 28.30B¥ 26.83B¥ 24.34B
Depreciation and Amortization
¥ 2.03B¥ 2.36B¥ 4.43B¥ 4.17B¥ 3.92B
EBITDA
¥ 19.26B¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B
Operating Income
¥ 16.04B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
Other Income/Expenses
¥ -1.24B¥ -2.19B¥ -697.06M¥ -2.04B¥ -2.71B
Pretax Income
¥ 14.80B¥ 14.00B¥ 19.51B¥ 18.56B¥ 17.00B
Net Income
¥ 7.16B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Per Share Metrics
Basic EPS
¥ 2.29¥ 2.26¥ 2.90¥ 2.73¥ 2.49
Diluted EPS
¥ 2.29¥ 2.26¥ 2.90¥ 2.73¥ 2.49
Weighted Average Shares Outstanding
 3.12B 3.12B 3.12B 3.12B 3.11B
Weighted Average Shares Outstanding (Diluted)
 3.12B 3.12B 3.12B 3.12B 3.11B
Currency in CNY

Sinopharm Group Co Earnings and Revenue History